[go: up one dir, main page]

FI861329L - Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat. - Google Patents

Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat. Download PDF

Info

Publication number
FI861329L
FI861329L FI861329A FI861329A FI861329L FI 861329 L FI861329 L FI 861329L FI 861329 A FI861329 A FI 861329A FI 861329 A FI861329 A FI 861329A FI 861329 L FI861329 L FI 861329L
Authority
FI
Finland
Prior art keywords
isoxazolyl
acid derivatives
oxamine
anvaendning
thiazole
Prior art date
Application number
FI861329A
Other languages
English (en)
Other versions
FI85473C (fi
FI861329A0 (fi
FI85473B (fi
Inventor
Angelo Carenzi
Dario Chiarino
Davide Della Bella
Giancarlo Grancini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI861329L publication Critical patent/FI861329L/fi
Publication of FI861329A0 publication Critical patent/FI861329A0/fi
Priority to FI911048A priority Critical patent/FI87354C/fi
Application granted granted Critical
Publication of FI85473B publication Critical patent/FI85473B/fi
Publication of FI85473C publication Critical patent/FI85473C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI861329A 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat och mellanprodukter. FI85473C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI911048A FI87354C (fi) 1984-07-31 1991-03-01 Foerfarande foer framstaellning av 2-amino-4-(isoxazolyl)tiazolderivat

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT2215084 1984-07-31
IT22150/84A IT1183061B (it) 1984-07-31 1984-07-31 Composti dotati di attivita'antiallergica
EP8500380 1985-07-30
PCT/EP1985/000380 WO1986000899A1 (en) 1984-07-31 1985-07-30 Use of 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives

Publications (4)

Publication Number Publication Date
FI861329L true FI861329L (fi) 1986-03-26
FI861329A0 FI861329A0 (fi) 1986-03-26
FI85473B FI85473B (fi) 1992-01-15
FI85473C FI85473C (fi) 1992-04-27

Family

ID=11192238

Family Applications (2)

Application Number Title Priority Date Filing Date
FI861329A FI85473C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat och mellanprodukter.
FI861330A FI83650C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI861330A FI83650C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.

Country Status (13)

Country Link
US (2) US4766138A (fi)
EP (2) EP0191045B1 (fi)
JP (2) JPS61502959A (fi)
AU (2) AU583847B2 (fi)
CA (2) CA1246583A (fi)
DE (2) DE3574874D1 (fi)
DK (2) DK142086A (fi)
ES (4) ES8608516A1 (fi)
FI (2) FI85473C (fi)
IL (1) IL75981A (fi)
IT (1) IT1183061B (fi)
WO (2) WO1986000900A1 (fi)
ZA (1) ZA855743B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
US4946963A (en) * 1987-11-13 1990-08-07 The University Of North Carolina At Chapel Hill Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
DE3844227A1 (de) * 1988-12-29 1990-07-05 Basf Ag 3(2h)-pyridazinonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
DE19625622A1 (de) * 1996-06-26 1998-01-02 Siemens Ag Lichtabstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
CN1264228C (zh) 1996-06-26 2006-07-12 奥斯兰姆奥普托半导体股份有限两合公司 发光半导体器件、全色发光二极管显示装置及其应用
DE19638667C2 (de) 1996-09-20 2001-05-17 Osram Opto Semiconductors Gmbh Mischfarbiges Licht abstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
CA2551611C (en) 2003-12-26 2013-06-25 Kyowa Hakko Kogyo Co., Ltd. Thiazole derivatives for treating or preventing parkinson's disease
EP1988077A4 (en) * 2006-02-23 2009-09-02 Shionogi & Co NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2429210A1 (fr) * 1978-06-19 1980-01-18 Fabre Sa Pierre Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme
DE3027527A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica

Also Published As

Publication number Publication date
CA1243318A (en) 1988-10-18
AU4671785A (en) 1986-02-25
EP0190298B1 (en) 1989-10-18
ES546420A0 (es) 1986-07-16
IT1183061B (it) 1987-10-05
IT8422150A0 (it) 1984-07-31
JPS61502896A (ja) 1986-12-11
ES546419A0 (es) 1987-02-16
EP0191045A1 (en) 1986-08-20
JPH0574592B2 (fi) 1993-10-18
IT8422150A1 (it) 1986-01-31
DE3573781D1 (en) 1989-11-23
CA1246583A (en) 1988-12-13
WO1986000900A1 (en) 1986-02-13
DK164364B (da) 1992-06-15
DK142086D0 (da) 1986-03-26
IL75981A0 (en) 1985-12-31
EP0190298A1 (en) 1986-08-13
FI85473C (fi) 1992-04-27
AU4724885A (en) 1986-02-25
CA1261847C (fi) 1989-09-26
JPH0576946B2 (fi) 1993-10-25
DK141986D0 (da) 1986-03-26
DK141986A (da) 1986-05-28
AU584118B2 (en) 1989-05-18
EP0191045B1 (en) 1989-12-20
ES8800217A1 (es) 1987-10-16
JPS61502959A (ja) 1986-12-18
AU583847B2 (en) 1989-05-11
FI861330L (fi) 1986-03-26
ZA855743B (en) 1986-05-28
DK164364C (da) 1992-11-02
ES8705434A1 (es) 1987-05-01
WO1986000899A1 (en) 1986-02-13
ES552514A0 (es) 1987-05-01
FI861329A0 (fi) 1986-03-26
DK142086A (da) 1986-05-29
FI861330A0 (fi) 1986-03-26
ES552513A0 (es) 1987-10-16
US4766138A (en) 1988-08-23
ES8608516A1 (es) 1986-07-16
DE3574874D1 (de) 1990-01-25
FI83650C (fi) 1991-08-12
ES8703459A1 (es) 1987-02-16
IL75981A (en) 1989-07-31
FI83650B (fi) 1991-04-30
FI85473B (fi) 1992-01-15
US4766137A (en) 1988-08-23

Similar Documents

Publication Publication Date Title
EE04239B1 (et) Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
IL58775A0 (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL58782A (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
DK542781A (da) Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
FI861329L (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
IT8019711A0 (it) Composizioni da usarsi come cosmetici e procedimento per lapreparazione dei loro ingredienti attivi.
IT7967043A0 (it) Derivati di aza i biciclo 2 2 2 octano prodotti intermedi procedimento per la loro preparazione e loro applicazione come medicinali
AU530678B2 (en) Phosphono-hydroxy-acetic acid
IT8322648A0 (it) Derivati dell'acido 4-fenil4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali.
PH15720A (en) Hypolipidemic derivatives of 4,5-dihydro-4-oxo-furan-2-carboxylic acid,their pharmaceutical compositions and method of use
IT1161974B (it) Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
JPS5536484A (en) Novel 1*44dihydropyridazinee33carboxylic acid derivative
IT8620703A0 (it) Derivati dell'acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali.
DE3264543D1 (en) Cyclic sulfenamides, process for their preparation, medicines containing them and preparation of the latter
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
FR2502617B1 (fi)
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
IT7948907A0 (it) Derivati di 1,3 benzodiossina procedimento per la loro produzione e composizioni farmaceutiche che licontengono come ingredienti attivi
IT7849168A0 (it) Derivati di 1,3-benzodiossina procedimento per la loro produzione e composizioni farmaceutiche che licontengono come ingredienti attivi
IT7827494A0 (it) Composizioni farmaceutiche e metodo per produrre attivita' antipsicotica senza sintomi extrapiramidali.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ZAMBON S.P.A.